Andrographolide dispersed tablet
A technology of andrographolide and dispersible tablets, which is applied in the direction of organic active ingredients, medical preparations containing active ingredients, pill delivery, etc., can solve the problems of poor absorption, slow dissolution of andrographolide tablets, and low bioavailability, and achieve Improve the dissolution rate, design a large room for maneuver, reduce the effect of dosage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0024] The weight percentage of traditional Chinese medicine extract and auxiliary materials of andrographolide dispersible tablets: fine powder of andrographolide extract 8%, low-substituted hydroxypropyl cellulose 28%, sodium carboxymethyl starch 28%, microcrystalline cellulose 10% , lactose 20%, polyvinylpyrrolidone 3%, magnesium stearate 3%.
[0025] The andrographolide dispersible tablet is obtained according to the following specific steps: the andrographolide is crushed into fine powder, and sieved to obtain the fine powder of the andrographolide extract.
[0026] First pass the above-mentioned materials through a 100-mesh sieve, and mix the fine powder of andrographolide extract, filler and disintegrant according to the method of equal incremental addition. , dissolve in an appropriate amount of water or ethanol to make a soft material; make wet granules through a 20-mesh sieve, dry, granulate through a 20-mesh sieve, add the rest of the auxiliary materials, mix well, ...
Embodiment 2
[0028] Fine powder of andrographolide extract by weight 24%, sodium carboxymethylcellulose 22%, crospovidone 16%, microcrystalline cellulose 14%, polyvinylpyrrolidone 5%, lactose 12%, polyethylene Pyrrolidone 4%, micronized silica gel 1%, magnesium lauryl sulfate 2%. All the other are with embodiment 1.
Embodiment 3
[0030] Fine powder of andrographolide extract by weight 35%, sodium carboxymethyl starch 15%, croscarmellose sodium 20%, crospovidone 6%, low-substituted hydroxypropyl cellulose 4% , mannitol 9%, polyvinylpyrrolidone 7%, micronized silica gel 3%, magnesium stearate 1%, HLB=15-16 sucrose fatty acid ester 1%. Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, all the other are the same as embodiment 1.
PUM
![No PUM](https://static-eureka-patsnap-com.libproxy1.nus.edu.sg/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka-patsnap-com.libproxy1.nus.edu.sg/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com